Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04124523
Other study ID # RECHMPL19_0468
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2019
Est. completion date October 1, 2019

Study information

Verified date September 2019
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Cerebrospinal fluid (CSF) leak is a rare condition. When it involves the ventral skull base, a surgical closure may be achieved using endoscopic skull base surgery techniques. The major principles remain in achieving a watertight closure that can also support the brain (and avoid brain sagging) in case of extensive skull base defects. Surgical techniques are well described. Many clinical factors may influence the successful rate of the reconstruction. However, there is a lack of clinical study on perioperative management of CSF leaks. The purpose of this study is to gather the opinion of skull base surgeons on the post-operative management of patients to avoid CSF leak recurrence.

•Methods: The investigators will collect data from skull base surgeons using an electronic survey questionnaire (Google Form, Google, Mountain View, California, U.S.A.) submitted by e-mail to the members of the French Association of Rhinology, to the European Rhinologic Society, to the French college of neurosurgeons, to the Italian skull base society members, and to the former students of the European endoscopic skull base diploma. This is an anonymous 60-items survey. Questions were classified in eight sections: general questions, material used at the end of the surgical procedure, post-operative resting position, drugs, CSF depletion, post-operative advices, explorations in case of early recurrence of the rhinorrhoea, and follow-up modalities.

•Discussion: The investigators aim to understand the actual practice of skull base surgeons after closure of ventral skull base CSF leaks. This can serve as a basis for conducting clinical studies in the future.


Recruitment information / eligibility

Status Completed
Enrollment 153
Est. completion date October 1, 2019
Est. primary completion date September 1, 2019
Accepts healthy volunteers No
Gender All
Age group 25 Years and older
Eligibility Inclusion criteria

An individual must fulfill all of the following criteria in order to be eligible for study enrollment:

- Active skull base surgery practice (ENT surgeon or neurosurgeon)

- Volunteering

Non inclusion criteria

- Subject unable to read or/and write

- Undergraduate students

- Refusal to participate

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Uh Montpellier Montpellier

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of perioperative management of CSF leaks Evaluation of perioperative management of CSF leaks at pre-treatment (preoperative) with 60 items questionnaire (QCM) 1 day (pre-treatment)
Primary Evaluation of perioperative management of CSF leaks Evaluation of perioperative management of CSF leaks at the end of the surgery with 60 items questionnaire (QCM) 1 day (the end of the surgery)
Primary Evaluation of perioperative management of CSF leaks Evaluation of perioperative management of CSF leaks during hospitalization with 60 items questionnaire (QCM) maximum 2 weeks (during hospitalization)
Secondary Comparison of practices of surgeons according by specialties Comparison of practices of surgeons according by specialties at pre-treatment (preoperative) with 60 items questionnaire (QCM) 1 day (pre-treatment)
Secondary Comparison of practices of surgeons according by specialties Comparison of practices of surgeons according by specialties at the end of the surgery with 60 items questionnaire (QCM) 1 day (the end of the surgery)
Secondary Comparison of practices of surgeons according by specialties Comparison of practices of surgeons according by specialties during hospitalization with 60 items questionnaire (QCM) maximum 2 weeks (during hospitalization)
See also
  Status Clinical Trial Phase
Completed NCT04057157 - Post-market Assessment of Biodesign Dural Repair Grafts
Withdrawn NCT02902133 - Acetazolamide to Prevent Post Operative CSF Leak Phase 2
Recruiting NCT02927782 - Mobilisation Algorithm After Incidental Durotomy N/A
Completed NCT03566602 - Evaluate the Safety and Performance of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery N/A
Completed NCT02891070 - Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery Phase 3
Recruiting NCT04490629 - The Efficacy and Safety of a Latest Dural Substitute N/A
Withdrawn NCT04351061 - Acetazolamide for the Prevention of Post Operative CSF Leak Phase 2
Recruiting NCT04086550 - Evaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery N/A
Completed NCT02457546 - The EVICEL® Neurosurgery Phase III Study Phase 3
Completed NCT04145544 - A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Commercially Available Dural Substitutes. To Evaluate the Safety and Effectiveness of ArtiFascia® in Subjects Requiring Dural Repair. N/A
Active, not recruiting NCT04923867 - Suturable DuraGen™ PMCF Study
Withdrawn NCT03181464 - Sphenopalatine Ganglion Nerve Block for Postdural Puncture Headache in Obstetrics Phase 4